Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | Oral chemotherapy for acute lymphoblastic leukaemia and inflammatory bowel disease. | Long-term immunosuppressant tablet. |
| Body system | Cancer | Joints & Immunity |
| Drug class | Antimetabolites | Antiproliferative immunosuppressants |
| Supply | Prescription onlyWHO essential medicine | Prescription onlyWHO essential medicine |
| Main uses | Acute lymphoblastic leukaemia (maintenance), Crohn's disease, Ulcerative colitis | Crohn's disease and ulcerative colitis, Autoimmune hepatitis, Lupus and vasculitis, Transplant rejection prevention, Myasthenia gravis |
| How it works | Blocks DNA building in fast-dividing cells. | Slows down overactive immune cells. |
| Starts working | Depends on the cancer and regimen | 2–3 months |
| Half-life | About 1–2 hours | — |
| Typical adult dose | Dosed by your cancer team according to the treatment protocol. | 1–2.5 mg/kg a day, depending on TPMT activity. |
| Forms | Tablet, Oral suspension | Tablet, Injection |
| Common side effects | Nausea, Low blood counts, Mouth sores, Loss of appetite | Nausea, Flu-like symptoms early, Tiredness |
| Serious side effects | Severe bone marrow suppression, Liver toxicity, Pancreatitis | Bone marrow suppression, Pancreatitis, Liver injury, Skin cancer and lymphoma |
| Don't take if | Pregnancy (unless essential); Severe TPMT deficiency | — |
| Alcohol | Best to limit. Alcohol may add to liver strain. | — |
| Pregnancy | Usually avoidedAvoid unless the specialist decides the benefit outweighs the risk. | Use with cautionOften continued in IBD and lupus when needed. |
| Breastfeeding | Use with cautionSpecialist decision. | — |
| In use since | — | 1968 |
| Brand names | United States: Purixan, PurinetholUnited Kingdom: Xaluprine, Mercaptopurine (generic)India: Purinethol, Mercaptopurine (generic) | United States: Imuran, AzasanUnited Kingdom: ImuranIndia: Azoran, Azimune |
| Legal status | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H | — |
| ATC code | L01BB02 | L04AX01 |
Taken together
- ModerateMercaptopurine + Azathioprine: Added bone marrow suppression
Both can lower white cells, red cells or platelets; together the risk of infection and bleeding rises.